These studies demonstrate that CD8+ T cells and NKT cells can simultaneously exert pro-tumoral and anti-tumoral responses, and that perhaps pro-tumoral responses predominate during progressive IBD and CRC. This evidence concerns the gene CD8A and colorectal carcinoma.